Project Grant R01CA299669
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded the University of Pennsylvania a Project Grant of $663,554 under the Cancer Cause and Prevention Research program (CFDA 93.393) on August 18, 2025, with an ultimate completion date of July 31, 2030. This research project, titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit," will develop and test harm reduction product sampling as a pragmatic...
- Federal Grant Award Summary The National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded the University of Alabama a Project Grant of $2,524,071 on September 23, 2025, for research investigating the neurocomputational mechanisms underlying self-regulation and reinforcement learning in smoking cessation decisions. The four-year project, with completion scheduled for August 31, 2029, will employ computational model-based multimodal neuroimaging...
- Federal Grant Award Summary The National Cancer Institute (National Institutes of Health) awarded Mayo Clinic a $823,878 Project Grant on September 4, 2025, under the Cancer Treatment Research program (CFDA 93.395) to conduct a Phase II randomized, double-blind clinical trial evaluating vagal nerve stimulation (VNS) as a novel neuromodulation treatment for tobacco use disorder. The research will assess the efficacy of combining active VNS with nicotine replacement therapy (NRT) compared to...
- Federal Grant Award Summary The National Cancer Institute awarded a $105,189 Project Grant to the Regents of the University of Minnesota under the Cancer Research Manpower program (CFDA 93.398) effective December 1, 2025, with completion targeted for June 30, 2027. This award funds research aimed at deciphering the structural dynamics and inhibition mechanisms of APOBEC3A (A3A) and APOBEC3B (A3B) enzymes, which play dual roles in host antiviral defense and genomic stability while contributing to...
- Federal Project Grant Award Summary Award Overview The National Cancer Institute (NCI) awarded a $654,688 Project Grant to Rutgers The State University of New Jersey's School of Nursing (RBHS-School of Nursing) under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a comprehensive retrospective analysis of flavored cigar policy implementation across U.S. municipalities. The five-year project, effective April 1, 2026 through March 31, 2031, will examine the real-world...
- Federal Project Grant Award Summary The National Cancer Institute awarded $158,895.00 to the Regents of the University of Michigan under the Cancer Research Manpower program (CFDA 93.398) on May 1, 2026, for a five-year project period concluding April 30, 2031. The award supports research training and career development activities designed to build the scientific workforce in cancer research. This project grant falls under the Cancer Research Manpower program's mandate to provide biomedical...
- Federal Grant Award Summary The National Cancer Institute awarded a $164,484 Project Grant to The University of Kentucky Research Foundation on August 11, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393). This award supports a research initiative focused on developing and evaluating health communications targeting adults who smoke nondaily (ASN)—a population representing approximately one-third of current adult cigarette smokers in the United States yet demonstrating...
- Federal Grant Award Summary Rutgers The State University of New Jersey, Robert Wood Johnson Health Sciences (RBHS)-School of Nursing received a $403,689 Project Grant award from the National Cancer Institute (NCI) effective August 1, 2025, through July 31, 2027, under the Cancer Cause and Prevention Research program (CFDA 93.393). The grant funds research investigating the influence of menthol cigarette smoking on lung cancer screening eligibility within a national prospective cohort study....
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded Rutgers The State University of New Jersey – Robert Wood Johnson Medical School (RBHS) School of Nursing a $687,511 Project Grant on August 14, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a randomized controlled trial examining charcoal-filtered cigarettes, specifically the Natural American Spirit brand's "Sky" product. The five-year project, extending through...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) totaling $885,824 aims to assess consumer response to smokeless tobacco modified risk marketing orders. The research activities will explore 1) consumers' exposure and reactions to authorized smokeless tobacco modified risk tobacco product (MRTP) claims, and 2) whether the MRTP claims influence smokeless tobacco demand and sensory evaluations. The project will be conducted...
The National Cancer Institute (NCI) awarded the Regents of the University of Minnesota a $621,549 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) for a five-year study commencing June 1, 2026 and concluding May 31, 2031. The research will evaluate how nicotine pouch characteristics influence tobacco product use patterns, particularly in the context of menthol cigarette bans. The study employs an experimental marketplace approach to assess the acceptability and substitutability of nicotine pouches relative to medicinal nicotine and combustible cigarettes among menthol smokers, with specific focus on how flavor variants affect product appeal and switching behavior from conventional cigarettes to non-combustible alternatives. The project addresses a critical gap in understanding emerging non-combustible tobacco products by investigating whether nicotine pouches—which present lower harm risk than combustible cigarettes—can serve as viable substitutes that reduce smoking prevalence without compromising complete cessation efforts. The research will generate evidence regarding consumer preference patterns for flavored versus unflavored pouches and quantify the impact of menthol cigarette bans on pouch adoption rates, ultimately informing cancer prevention policy and public health strategy related to tobacco harm reduction and regulatory interventions.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $621.5k | 5/22/26 |